Brief: BB Biotech Q1 Net Loss At CHF 254 Mln

Bb Biotech

21/04/2023 06:03

April 21 (Reuters) - BB BIOTECH AG  BION.S :
    * LACKLUSTER FIRST QUARTER FOR BIOTECH STOCKS
    * TOTAL RETURN FOR Q1 2023 OF -4.4% IN CHF AND -6.8% IN EUR
(INCLUDING DIVIDEND PAYMENT OF CHF 2.85 PER SHARE)
    * CONSEQUENTLY, NET LOSS FOR Q1 OF 2023 WAS CHF 254 MN
COMPARED TO
A NET LOSS OF CHF 300 MN FOR SAME PERIOD IN 2022
    * TOTAL RETURN FOR PORTFOLIO WAS -9.2% IN CHF, -9.4% IN EUR
AND
-8.3% IN USD, BEHIND NBI INDEX BUT IN LINE WITH S&P BIOTECH
SELECT INDUSTRY INDEX
    * PROPOSAL TO PAY A DIVIDEND OF CHF 2.85 GROSS PER SHARE,
RESULTING IN A TOTAL OF CHF 156 MN PAID TO SHAREHOLDERS OF BB
BIOTECH ON MARCH 29, 2023

Source text for Eikon:  ID:nEQ1nSwn4a 
Further company coverage:  BION.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))